LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Video & Transcript
Capitol Directory (Beta)
US
Connecticut CT
Legislatures
2016 Regular Session
Senate
Bills
SB00313
CT
Connecticut Senate Bill SB00313
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Connecticut 2016 Regular Session
Connecticut Senate Bill SB00313
Introduced
2/25/16
Introduced
2/25/16
Refer
2/25/16
Refer
2/25/16
Report Pass
3/11/16
Report Pass
3/11/16
Refer
3/18/16
Refer
3/18/16
Report Pass
3/24/16
Report Pass
3/24/16
Caption
An Act Concerning Biological Products.
Latest CT SB00313 Activity
View All Events: CT 2016 Regular Session SB00313
Companion Bills
No companion bills found.
Previously Filed As
CT HB05235
An Act Concerning The Department Of Consumer Protection's Recommendations Regarding Cannabis Regulation.
CT SB00133
An Act Concerning Regulation Of Prescription Drugs And Related Professions.
CT SB00008
An Act Concerning Drug Affordability.
CT HB05150
An Act Concerning Cannabis And Hemp Regulation.
CT SB00292
An Act Concerning The Use Of Pfas In Certain Products.
CT SB00202
An Act Concerning The Department Of Consumer Protection's Recommendations Regarding Prescription Drug Control.
CT HB05198
An Act Concerning Telehealth.
CT HB05290
An Act Concerning Various Revisions To The Public Health Statutes.
CT HB05488
An Act Concerning Various Revisions To The Public Health Statutes.
CT HB05054
An Act Addressing Health Care Affordability.
Similar Bills
CT SB00197
An Act Concerning Biological Products.
CT HB07118
An Act Concerning Biological Products.
TX SB542
Relating to the prescription and pharmaceutical substitution of biological products.
TX HB751
Relating to the prescription and pharmaceutical substitution of biological products; amending provisions subject to a criminal penalty.
UT SB0236
Pharmacy Practice Amendments
TX SB190
Relating to the prescription and pharmaceutical substitution of biological products.
TX HB542
Relating to the prescription and pharmaceutical substitution of biological products.
OR SB441
Relating to biological products.